{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:55:30Z","timestamp":1781528130822,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018217","name":"Universidade Federal de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.msard.2026.107153","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T15:53:14Z","timestamp":1774194794000},"page":"107153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predictors of early NEDA-3 status after first disease-modifying therapy in a real-world Brazilian multiple sclerosis cohort"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9937-5982","authenticated-orcid":false,"given":"Fl\u00e1via Timb\u00f3","family":"Albuquerque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7332-2658","authenticated-orcid":false,"given":"Felipe Toscano Lins","family":"de Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5559-1269","authenticated-orcid":false,"given":"Natasha Pryanka de Ara\u00fajo","family":"Bessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1287-690X","authenticated-orcid":false,"given":"Nilton Amorim","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4011-3734","authenticated-orcid":false,"given":"Denis Bernardi","family":"Bichuetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4939-7200","authenticated-orcid":false,"given":"Enedina Maria Lobato","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107153_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105015","article-title":"Prevalence of 2-year \u201cno evidence of disease activity\u201d (NEDA-3 and NEDA-4) in relapsing-remitting multiple sclerosis: a real-world study","volume":"79","author":"Bazzurri","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10076","key":"10.1016\/j.msard.2026.107153_bib0002","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(16)32388-1","article-title":"Evolving concepts in the treatment of relapsing multiple sclerosis","volume":"389","author":"Comi","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.msard.2026.107153_bib0003","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1212\/WNL.0000000000006810","article-title":"Unraveling treatment response in multiple sclerosis: a clinical and MRI challenge","volume":"92","author":"Gasperini","year":"2019","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.msard.2026.107153_bib0004","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.msard.2026.107153_bib0005","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/1352458517703193","article-title":"No evident disease activity: the use of combined assessments in the management of patients with multiple sclerosis","volume":"23","author":"Giovannoni","year":"2017","journal-title":"Mult. Scler."},{"issue":"Suppl 3","key":"10.1016\/j.msard.2026.107153_bib0006","first-page":"S3","article-title":"Freedom from disease activity in multiple sclerosis","volume":"74","author":"Havrdova","year":"2010","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2026.107153_bib0007","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/ene.13669","article-title":"No evidence of disease activity' \u2013 is it an appropriate surrogate in multiple sclerosis?","volume":"25","author":"Hegen","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2026.107153_bib0008","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1212\/WNL.0000000000011242","article-title":"Effect of disease-modifying therapy on disability in relapsing-remitting multiple sclerosis over 15 years","volume":"96","author":"Kalincik","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107153_bib0009","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.msard.2017.12.016","article-title":"The evolution of \u201cno evidence of disease activity\u201d in multiple sclerosis","volume":"20","author":"Lu","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107153_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101935","article-title":"No evidence of disease activity\u201d: is it an aspirational therapeutic goal in multiple sclerosis?","volume":"40","author":"Mayssam","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"21","key":"10.1016\/j.msard.2026.107153_bib0011","first-page":"2211","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.msard.2026.107153_bib0012","doi-asserted-by":"crossref","first-page":"e1059","DOI":"10.1212\/NXI.0000000000001059","article-title":"Prognostic accuracy of NEDA-3 in long-term outcomes of multiple sclerosis","volume":"8","author":"Prosperini","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.msard.2026.107153_bib0013","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2026.107153_bib0014","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jamaneurol.2014.3537","article-title":"Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort","volume":"72","author":"Rotstein","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2026.107153_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1034056","article-title":"Rebaseline no evidence of disease activity (NEDA-3) as a predictor of long-term disease course in a Norwegian multiple sclerosis population","volume":"13","author":"Simonsen","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107153_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.693017","article-title":"Early high efficacy treatment in multiple sclerosis is the best predictor of future disease activity over 1 and 2 years in a Norwegian population-based registry","volume":"12","author":"Simonsen","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107153_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102875","article-title":"No evidence of disease activity-3 (NEDA-3) status in patients with relapsing-remitting multiple sclerosis: evidence from a Saudi cohort mainly receiving interferon","volume":"51","author":"Zafar","year":"2021","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:21:29Z","timestamp":1781526089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826001896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":17,"alternative-id":["S2211034826001896"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107153","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of early NEDA-3 status after first disease-modifying therapy in a real-world Brazilian multiple sclerosis cohort","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107153"}}